Patents by Inventor Jeffrey Etter

Jeffrey Etter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11724085
    Abstract: Systems and methods of disinfection of catheter connections are provided. A transfer catheter connector can include a UV-transparent window at its distal end and a sealing plunger proximal to the UV-transparent window. A solution set connector can be inserted inside a portion of the transfer catheter connector to connect a solution set and transfer catheter. The solution set connector comprises a lumen covered by a leading membrane surface; a sealing surface configured to sealingly engage the window surface, and a piercing member configured to pierce the membrane surface. The sealing plunger, membrane surface, and window define a disinfection zone. The connectors can be connected in a disinfection position configuration in which flow is not permitted between the catheters and the connectors are irradiated with UV light. After disinfection, the connectors are advanced to a flow position in which the piercing member pierces the membrane surface, enabling flow between the catheters.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: August 15, 2023
    Assignee: PURACATH MEDICAL, INC.
    Inventors: Justin A. Lance, Stephen Bower, John E. Ashley, Jeffrey Etter, Julia A. Rasooly, Michael Rasooly, Benjamin S. Arnett
  • Publication number: 20230110737
    Abstract: Hand held and portable disinfection units for use with patients having indwelling catheters or are hospitalized or under care in an intensive care unit.
    Type: Application
    Filed: September 12, 2022
    Publication date: April 13, 2023
    Applicant: PURACATH MEDICAL, INC.
    Inventors: Jeffrey ETTER, John E. ASHLEY, Ian TRAN, Jochen BACKS, Julia A. RASOOLY
  • Patent number: 11439716
    Abstract: Hand held and portable disinfection units for use with patients having indwelling catheters hospitalized or under care in an intensive care unit.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: September 13, 2022
    Assignee: PURACATH MEDICAL, INC.
    Inventors: Jeffrey Etter, John E. Ashley, Ian Tran, Jochen Backs, Julia A. Rasooly
  • Publication number: 20220203004
    Abstract: Dialysis systems and methods are described which can include a number of features. The dialysis systems described can be to provide dialysis therapy to a patient in the comfort of their own home. The dialysis system can be configured to prepare purified water from a tap water source in real-time that is used for creating a dialysate solution. The dialysis systems described also include features that make it easy for a patient to self-administer therapy.
    Type: Application
    Filed: April 30, 2020
    Publication date: June 30, 2022
    Applicant: OUTSET MEDICAL, INC.
    Inventors: Dean HU, Justin Thomas PUZIN, Steven Owen MILLER, Tyler John MILLER, Logan RIVAS, Michael KIM, Michael Edward HOGARD, Jeffrey ETTER, Todd NELSON, James TUMBER, Stephanie KLUNK, Paul BRAYFORD, Cole NAYMARK
  • Publication number: 20210346143
    Abstract: A container for a medical device having a housing defining a cavity for receiving the device, a coupling zone external to the cavity, and an exit aperture between the cavity and the coupling zone; and a bearing surface located within the cavity, the bearing surface, exit aperture and coupling zone defining an exit path along which the device can be moved for deployment from the container. The bearing surface is spaced from the exit aperture and arranged, together with the coupling zone, such that the exit path is substantially straight. The cavity is approximately cylindrical, and the bearing surface, the exit aperture, and the coupling zone are aligned such that the exit path extends in a direction that is substantially tangential to the cavity. The housing comprises a two part structure joined together in a plane substantially orthogonal to the exit path. The housing defines a substantially unobstructed cavity for receiving the device.
    Type: Application
    Filed: September 8, 2017
    Publication date: November 11, 2021
    Applicant: PneumRx, Inc.
    Inventors: David Lehrberg, Mark Mathis, Jeffrey Etter, Verna Rodriguez
  • Publication number: 20210252270
    Abstract: Systems and methods of disinfection of catheter connections are provided. A transfer catheter connector can include a UV-transparent window at its distal end and a sealing plunger proximal to the UV-transparent window. A solution set connector can be inserted inside a portion of the transfer catheter connector to connect a solution set and transfer catheter. The solution set connector comprises a lumen covered by a leading membrane surface; a sealing surface configured to sealingly engage the window surface, and a piercing member configured to pierce the membrane surface. The sealing plunger, membrane surface, and window define a disinfection zone. The connectors can be connected in a disinfection position configuration in which flow is not permitted between the catheters and the connectors are irradiated with UV light. After disinfection, the connectors are advanced to a flow position in which the piercing member pierces the membrane surface, enabling flow between the catheters.
    Type: Application
    Filed: March 17, 2021
    Publication date: August 19, 2021
    Applicant: PuraCath Medical, Inc.
    Inventors: Justin A. LANCE, Stephen BOWER, John E. ASHLEY, Jeffrey ETTER, Julia A. RASOOLY, Michael RASOOLY, Benjamin S. ARNETT
  • Publication number: 20210113725
    Abstract: Hand held and portable disinfection units for use with patients having indwelling catheters or are hospitalized or under care in an intensive care unit.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 22, 2021
    Inventors: Jeffrey Etter, John E. Ashley, Ian Tran, Jochen Backs, Julia A. Rasooly, Michael G. Fourkas
  • Patent number: 10953217
    Abstract: Systems and methods of disinfection of catheter connections are provided. A transfer catheter connector can include a UV-transparent window at its distal end and a sealing plunger proximal to the UV-transparent window. A solution set connector can be inserted inside a portion of the transfer catheter connector to connect a solution set and transfer catheter. The solution set connector comprises a lumen covered by a leading membrane surface; a sealing surface configured to sealingly engage the window surface, and a piercing member configured to pierce the membrane surface. The sealing plunger, membrane surface, and window define a disinfection zone. The connectors can be connected in a disinfection position configuration in which flow is not permitted between the catheters and the connectors are irradiated with UV light. After disinfection, the connectors are advanced to a flow position in which the piercing member pierces the membrane surface, enabling flow between the catheters.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: March 23, 2021
    Assignee: PuraCath Medical, Inc.
    Inventors: Justin A. Lance, Stephen Bower, John E. Ashley, Jeffrey Etter, Julia A. Rasooly, Michael Rasooly, Benjamin S. Arnett
  • Publication number: 20200188543
    Abstract: Hand held and portable disinfection units for use with patients having indwelling catheters hospitalized or under care in an intensive care unit.
    Type: Application
    Filed: July 11, 2017
    Publication date: June 18, 2020
    Inventors: Jeffrey ETTER, John E. ASHLEY, Ian TRAN, Jochen BACKS, Julia A. RASOOLY
  • Publication number: 20190099430
    Abstract: A tablet including high dosage of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt has been disclosed.
    Type: Application
    Filed: October 8, 2018
    Publication date: April 4, 2019
    Inventor: Jeffrey Etter
  • Patent number: 10130636
    Abstract: A tablet including high dosage of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt has been disclosed.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: November 20, 2018
    Assignee: Clovis Oncology, Inc.
    Inventor: Jeffrey Etter
  • Publication number: 20180200260
    Abstract: A tablet including high dosage of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt has been disclosed.
    Type: Application
    Filed: March 14, 2018
    Publication date: July 19, 2018
    Inventor: Jeffrey Etter
  • Patent number: 9987285
    Abstract: A tablet including high dosage of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt has been disclosed.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: June 5, 2018
    Assignee: CLOVIS ONCOLOGY, INC.
    Inventor: Jeffrey Etter
  • Publication number: 20170156732
    Abstract: Methods, systems and devices are disclosed for the efficient and coordinated delivery of COPD treatment to the lung(s) of a patient. A lung volume reduction system is disclosed comprising an implantable device adapted to be delivered to an airway of a patient in a constrained configuration and to change to a tissue-compressing configuration when deployed at a target zone to provide treatment to the lung airway. The invention further discloses a method of quickly and efficiently deploying the device using a single coordinated motion or signal which may be particularly useful when multiple devices are deployed at multiple target zones.
    Type: Application
    Filed: February 14, 2017
    Publication date: June 8, 2017
    Applicant: PneumRx, Inc.
    Inventors: David Lehrberg, Mark L. Mathis, Verna Rodriguez, Jeffrey Etter, Kevin Mitz, Christoph Steven
  • Publication number: 20160271312
    Abstract: Systems and methods of disinfection of catheter connections are provided. A transfer catheter connector can include a UV-transparent window at its distal end and a sealing plunger proximal to the UV-transparent window. A solution set connector can be inserted inside a portion of the transfer catheter connector to connect a solution set and transfer catheter. The solution set connector comprises a lumen covered by a leading membrane surface; a sealing surface configured to sealingly engage the window surface, and a piercing member configured to pierce the membrane surface. The sealing plunger, membrane surface, and window define a disinfection zone. The connectors can be connected in a disinfection position configuration in which flow is not permitted between the catheters and the connectors are irradiated with UV light. After disinfection, the connectors are advanced to a flow position in which the piercing member pierces the membrane surface, enabling flow between the catheters.
    Type: Application
    Filed: March 18, 2016
    Publication date: September 22, 2016
    Inventors: Justin A. LANCE, Stephen BOWER, John E. ASHLEY, Jeffrey ETTER, Julia A. RASOOLY, Michael RASOOLY, Benjamin S. ARNETT
  • Publication number: 20160051561
    Abstract: A tablet including high dosage of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt has been disclosed.
    Type: Application
    Filed: August 17, 2015
    Publication date: February 25, 2016
    Inventor: Jeffrey Etter
  • Patent number: 7753916
    Abstract: An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.
    Type: Grant
    Filed: June 26, 2006
    Date of Patent: July 13, 2010
    Inventors: David A. Weber, Ingrid Kane, Mike Rehal, Robert L. Lathrop, Kenny Aptekarev, Jeffrey Etter
  • Patent number: 7468065
    Abstract: An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: December 23, 2008
    Assignee: Allergan, Inc.
    Inventors: David A. Weber, Ingrid Kane, Mike Rehal, Robert L. Lathrop, III, Kenny Aptekarev, Jeffrey Etter, Scott Gerondale, Rahul Bhagat, Shawn Davis
  • Publication number: 20070293698
    Abstract: The present invention provides novel compositions of allosteric hemoglobin modifiers which are substantially free of impurities, specifically polymeric impurities. In one embodiment, the novel compositions contain an allosteric hemoglobin modifier compound and less than 100 ppm of the polymeric impurities generated during the preparation of this compound. Included in the present invention are novel methods for preparing allosteric hemoglobin modifiers that are substantially free of polymeric impurities. Also included in the present invention are improved methods for the purification of the product formed by the method of this invention. The novel methods of purification comprise extracting the crude composition with a water immiscible or partially immiscible solvent such as methylisobutyl ketone (MIBK) to lower amounts of impurities, specifically polymeric impurities.
    Type: Application
    Filed: April 22, 2005
    Publication date: December 20, 2007
    Applicant: ALLOS THERAPEUTICS, INC.
    Inventors: Al Quick, Antonio Santos, Alexandre J.G. Carvalho, Douglas Johnson, Jeffrey Etter, Chris Murray
  • Publication number: 20070116776
    Abstract: Provided is a compressed anti-solvent technique for manufacture of drug-containing powders for pulmonary delivery. The drug is processed in a cosolvent system including two or more mutually soluble organic solvents. Also provided are powders manufacturable by the manufacture method, including powders of substantially pure drug and powders including a biocompatible polymer for pulmonary sustained drug release applications. Also provided are packaged products including drug-containing powder in a container that is receivable by and operable with a dry powder inhaler to produce an aerosol including dispersed drug-containing particles when the inhaler is actuated.
    Type: Application
    Filed: October 23, 2006
    Publication date: May 24, 2007
    Inventor: Jeffrey Etter